
Lifeloc Technologies, Inc
100
Recent news highlights Lifeloc Technologies securing financing for growth and being recognized as a company with real revenue in its sector.
- Lifeloc Technologies secured financing aimed at supporting innovative growth initiatives as of March 28, 2026 [N9].
- The company is identified among nuclear stocks with real revenue, distinguishing it from pre-revenue peers in a Nasdaq article dated August 17, 2026 [N1].
Lifeloc Technologies, Inc specializes in breath alcohol testing devices utilizing fuel cell technology, a mature technology developed over many years. The company operates in a competitive industry with larger competitors possessing greater resources. It relies on a limited number of customers and global third-party suppliers, exposing it to risks from economic, geopolitical, and natural events. The company manages cybersecurity risks through third-party providers and maintains oversight via its Audit Committee. Financially, Lifeloc reported revenues of $2.44 million and a net loss of $134,330 for the quarter ended June 30, 2026, with a strong current ratio of 4.35 and cash ratio of 2.05. The principal stockholder owns a controlling interest, influencing corporate governance and strategic decisions. The company has outstanding debt obligations with balloon payments due in 2030 and 2031. Lifeloc has not paid dividends and intends to retain earnings to support operations and expansion [S1][S2].
Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice. Lifeloc Technologies, Inc operates in the breath alcohol measurement device industry using fuel cell technology. The company faces competitive pressures from larger firms and risks from global events, cybersecurity, and customer concentration. As of June 30, 2026, it reported revenues of approximately $2.44 million and a net loss of $134,330, with strong liquidity ratios. The principal stockholder holds significant control. Recent news highlights financing secured for growth and confirms revenue generation [S1][S2][N1][N9].
Lifeloc's established fuel cell technology and existing customer base provide a foundation for continued revenue generation. The company's strong liquidity position as of mid-2026 supports operational stability. Securing financing for innovative growth indicates management's intent to invest in product development and market expansion. The company's focus on cybersecurity risk management and compliance with evolving regulations may enhance customer trust and market acceptance [S1][S2][N9].
The company faces significant risks from competition by larger firms with greater resources, which may limit market share and pricing power. Customer concentration poses revenue volatility risks if key customers reduce or cease purchases. Global economic instability, geopolitical conflicts, and supply chain disruptions could adversely affect operations and financial performance. The principal stockholder's controlling interest may raise governance concerns. Outstanding debt obligations require ongoing servicing, which could constrain financial flexibility if cash flows decline. Labor shortages and challenges in attracting technical talent may impede innovation and product development [S1].
Lifeloc's moat is based on its specialized fuel cell technology for breath alcohol measurement, which has been developed and refined over many years. However, the company faces competition from larger, better-financed firms with superior research, marketing, and manufacturing capabilities. The technology is mature but subject to potential obsolescence if competitors develop superior or lower-cost alternatives. Customer concentration and reliance on third-party suppliers also present challenges to maintaining a durable competitive advantage [S1].
• Competition and Market Risks: Lifeloc faces competition from larger, well-financed companies with superior research, marketing, and manufacturing capabilities. Technological obsolescence and commoditization risks exist if competitors develop superior or lower-cost products.
• Customer Concentration: A small number of customers account for a significant portion of revenues, creating dependency and potential revenue volatility if these customers reduce or stop purchases.
• Operational Risks from External Events: Natural disasters, public health crises, political instability, and other catastrophic events could disrupt operations, supply chains, and sales.
• Cybersecurity and Data Privacy Risks: The company stores information online and is subject to data privacy and cybersecurity regulations. Cybersecurity breaches could cause legal liability, financial costs, and reputational harm.
• Financial and Liquidity Risks: Outstanding indebtedness with balloon payments due in 2030 and 2031 requires cash flow for servicing. Failure to meet obligations could adversely affect the business. Economic instability may impact financing availability and costs.
• Governance Risks: The principal stockholder owns approximately 77% of the company’s stock, controlling board composition and strategic decisions, which may not align with minority shareholders' interests.
• Talent Acquisition and Retention Risks: The company depends on attracting and retaining employees with scientific and technical skills. Labor shortages and competition for talent may impair innovation and operations.
Business trends: The company operates in a competitive breath alcohol measurement market with ongoing innovation and customer concentration risks. Execution milestones: Maintaining product development, managing cybersecurity risks, and servicing debt obligations are key operational focuses. Key risks: Competitive pressures, customer dependency, external event disruptions, cybersecurity vulnerabilities, financial obligations, and governance concentration remain significant challenges.
Very high visibility
Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).
- Lifeloc Technologies, Inc uses fuel cell technology for breath alcohol measurement devices, a technology developed and refined over many years by the company and its major competitors [S1].
- The company faces competition from larger, well-financed competitors with superior research, marketing, and manufacturing capabilities [S1].
- Lifeloc's business is subject to risks from natural disasters, public health crises, political crises, and other catastrophic events that could disrupt operations or sales [S1].
- The company relies on global third-party suppliers and service providers, which may be impacted by events outside of its control, potentially harming operating results [S1].
- Increasing data privacy and cybersecurity regulations impact the use and market for Lifeloc's products; the company stores information online and may be vulnerable to cybersecurity attacks, which could cause legal liability and require financial resources to address [S1].
- Lifeloc's liquidity as of 2026-06-30 includes cash and equivalents of $2.25 million, current assets of $4.78 million, and current liabilities of $1.10 million, resulting in a current ratio of 4.35 and a cash ratio of 2.05 [S2].
- For the quarter ended 2026-06-30, Lifeloc reported revenues of approximately $2.44 million and a net loss of $134,330, with basic and diluted EPS of -$0.05 [S2].
- The company is dependent on a small number of customers, with three customers accounting for 18% of product sales in 2025 and 16% in 2024; accounts receivable are concentrated with one customer representing 46% of the balance as of December 31, 2025 [S1].
- Lifeloc's principal stockholder, Vern D. Kornelsen, beneficially owned approximately 77% of outstanding common stock as of December 31, 2025, giving him significant control over the company [S1].
- The company has outstanding indebtedness including subordinated debentures and a mortgage on its corporate headquarters, with balloon payments due in 2030 and 2031 respectively; servicing this debt depends on generating cash from operations [S1].
- Lifeloc has never declared or paid cash dividends and intends to retain earnings to support operations and expansion [S1].
- The company faces risks from unstable market and economic conditions, including inflation, liquidity constraints, and geopolitical conflicts that may affect its operations and financial performance [S1].
- Lifeloc's ability to attract and retain employees with scientific and technical skills is critical to its success; labor shortages pose a risk to the business [S1].
- The company invests in research and development to develop new and enhanced products and services; failure to innovate timely could result in obsolescence and harm the business [S1].
- Lifeloc's cybersecurity risk management relies on third-party providers and outsourced IT services; management regularly assesses risks and reports to the Audit Committee [S1].
- Recent news includes Lifeloc Technologies securing financing for innovative growth as of March 28, 2026 [N9].
- The company is mentioned in a Nasdaq article comparing nuclear stocks with real revenue versus pre-revenue companies, indicating Lifeloc has real revenue [N1].
Generated 2026-08-17
- Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice.
- S1 | 2026-03-27 | 10-K
- S2 | 2026-08-13 | 10-Q
- N1 | 2026-08-17 | www.nasdaq.com | 3 Nuclear Stocks With Real Revenue vs. 3 That Are Still Pre-Revenue. Here's Where the Money Actually Is. | https://www.nasdaq.com/articles/3-nuclear-stocks-real-revenue-vs-3-are-still-pre-revenue-heres-where-money-actually
- N2 | 2026-08-17 | www.nasdaq.com | Gain Posts Narrower Loss In Q2; Phase 1b Data For Rexaceract Due In Q4 2026 | https://www.nasdaq.com/articles/gain-posts-narrower-loss-q2-phase-1b-data-rexaceract-due-q4-2026
- N3 | 2026-08-17 | www.nasdaq.com | JB Hi-Fi Full-year Profit, Sales Rise; Raises Dividend | https://www.nasdaq.com/articles/jb-hi-fi-full-year-profit-sales-rise-raises-dividend
- N4 | 2026-08-17 | www.nasdaq.com | Kjell Group Loss Narrows In Q2 | https://www.nasdaq.com/articles/kjell-group-loss-narrows-q2
- N5 | 2026-08-17 | www.nasdaq.com | BlueScope Steel FY26 Profit Surges, Plans Dividend; Issues H1 View | https://www.nasdaq.com/articles/bluescope-steel-fy26-profit-surges-plans-dividend-issues-h1-view
- N6 | 2026-08-17 | www.nasdaq.com | National Australia Bank Q3 Profit Rises 9% To A$1.81 Bln | https://www.nasdaq.com/articles/national-australia-bank-q3-profit-rises-9-181-bln
- N7 | 2026-08-17 | www.nasdaq.com | A2 Milk FY26 Profit Down, Adj. EBITDA Rises; Sees Weak Margin In H1, Growth In FY27; Stock Drops | https://www.nasdaq.com/articles/a2-milk-fy26-profit-down-adj-ebitda-rises-sees-weak-margin-h1-growth-fy27-stock-drops
- N8 | 2026-08-17 | www.nasdaq.com | HUTCHMED's ORPATHYS-TAGRISSO Combo Shows Significant PFS, OS Benefit In Phase III Trial | https://www.nasdaq.com/articles/hutchmeds-orpathys-tagrisso-combo-shows-significant-pfs-os-benefit-phase-iii-trial
This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.

Generated by Valye SEC Pipeline Engine
.gif)


